Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
Author
Tuzun, E.
Pehlivan, M.
Ulusoy, C.
Icoz, S.
Kurtuncu, M.
Petek-Balci, B.
Birday, E.
Turkoglu, R.
Akman-Demir, G.
Eraksoy, M.
Coban, A.
Metadata
Show full item recordCollections
- Bildiri [64839]